Vitamin D plasma levels and in-hospital and 1-year outcomes in acute coronary syndromes

Medicine (United States)

Volumn 94, Issue 19, 2015, Pages

  De Metrio, Monica ^a   Milazzo, Valentina ^a   Rubino, Mara ^a   Cabiati, Angelo ^a   Moltrasio, Marco ^a   Marana, Ivana ^a   Campodonico, Jeness ^a   Cosentino, Nicola ^a   Veglia, Fabrizio ^a   Bonomi, Alice ^a   Camera, Marina ^a,b   Tremoli, Elena ^a,b   Marenzi, Giancarlo ^a  

^a CENTRO CARDIOLOGICO MONZINO   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

coronary syndromes; mortality; NSTEMI; STEMI; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; 25-HYDROXYVITAMIN D; VITAMIN D;

ACUTE CORONARY SYNDROME; AGED; COHORT ANALYSIS; FEMALE; FOLLOW UP; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MORBIDITY; MORTALITY; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVIEW; RISK FACTOR; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN D INSUFFICIENCY; VITAMIN DEFICIENCY; ANALOGS AND DERIVATIVES; BLOOD; COMORBIDITY; MIDDLE AGED; PROGNOSIS; VERY ELDERLY;

ACUTE CORONARY SYNDROME; AGED; AGED, 80 AND OVER; COMORBIDITY; FEMALE; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84938861029     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000000857     Document Type: Review

References (48)

1. Lavie CJ, Lee J, Milani R. Vitamin D and cardiovascular disease. Will it live up to its hype?. J Am Coll Cardiol. 2011; 58: 1547-1556
2. Vanga S, Good M, Howard P, et al. Role of vitamin D in cardiovascular health. Am J Cardiol. 2010; 106: 798-805
3. Pittas AG, Lau J, Hu FB, et al. The role of vitamin D and calcium in type 2 diabetes: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2007; 92: 2017-2029
4. Nainby-Luxmoore JC, Langford HG, Nelson NC, et al. A casecomparison study of hypertension and hyperparathyroidism. J Clin Endocrinol Metab. 1982; 55: 303-306
5. Saleh FN, Schirmer H, Sundsfjord J, et al. Parathyroid hormone and left ventricular hypertrophy. Eur Heart J. 2003; 24: 2054-2060
6. Holick MF. Vitamin D deficiency. N Engl J Med. 2007; 357: 266-281
7. Gonzalez EA, Sachdeva A, Oliver DA, et al. Vitamin D insufficiency and deficiency in chronic kidney disease. A single center observational study. Am J Nephrol. 2004; 24: 503-510
8. Gotsman I, Shauer A, Zwas DR, et al. Vitamin D deficiency is a predictor of reduced survival in patients with heart failure; vitamin D supplementation improves outcome. Eur J Heart Fail. 2012; 14: 357-366
9. Zittermann A, Schleithoff SS, Koerfer R. Vitamin D and vascular calcification. Curr Opin Lipidol. 2007; 18: 41-46
10. Lee JH, Gadi R, Spertus JA, et al. Prevalence of vitamin D deficiency in patients with acute myocardial infarction. Am J Cardiol. 2011; 107: 1636-1638
11. Khalili H, Talazaz AH, Salarifar M. Serum vitamin D concentration status and its correlation with early biomarkers of remodeling following acute myocardial infarction. Clinical Res Cardiology. 2012; 101: 321-327
12. De Metrio M, Milazzo V, Marenzi G. Serum vitamin D concentration status and its correlation with early biomarkers of remodeling following acute myocardial infarction. Clin Res Cardiol. 2012; 101: 771-772
13. Correia LCL, Sodrè F, Garcia G, et al. Relation of severe deficiency of vitamin D to cardiovascular mortality during acute coronary syndromes. Am J Cardiol. 2013; 111: 324-327
14. Ng LL, Sandhu JK, Squire IB, et al. Vitamin D and prognosis in acute myocardial infarction. Int J Cardiol. 2013; 168: 2341-2346
15. Li YC. Vitamin D regulation of the renin-angiotensin system. J Cell Biochem. 2003; 88: 327-331
16. Borges AC, Feres T, Vianna LM, et al. Effect of cholecalciferol treatment on the relaxant responses of spontaneously hypertensive rat arteries to acetylcholine. Hypertension. 1999; 134: 897-901
17. Schleithoff SS, Zittermann A, Tenderich G, et al. Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial. Am J Clin Nutr. 2006; 83: 754-759
18. Ortega A, Perez De Prada MT, González-Armengol JJ, et al. Effect of parathyroid-hormone-related protein on human platelet activation. Clinical Science. 2007; 113: 319-327
19. Mancuso P, Rahman A, Hershey SD, et al. 1,25-Dihydroxyvitamin- D3 treatment reduces cardiac hypertrophy and left ventricular diameter in spontaneously hypertensive heart failure prone (cp/) rats independent of changes in serum leptin. J Cardiovasc Pharmacol. 2008; 51: 559-564
20. Pilz S, Marz W, Wellnitz B, et al. Association of Vitamin D deficiency with heart failure and sudden cardiac death in a large cross sectional study of patient referred for coronary angiography. J Clin Endocrinol Metab. 2008; 93: 3927-3935
21. Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2011; 96: 1911-1930
22. Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med. 1999; 130: 461-470
23. Palmerini T, Genereux P, Caixeta A, et al. Prognostic value of the SYNTAX score in patient with acute coronary syndromes undergoing percutaneos coronary intervention. J Am Coll Cardiol. 2011; 57: 2389-2397
24. Levin A, Warnock DG, Mehta RL, et al. Improving outcomes from acute kidney injury: report of an initiative. Am J Kidney Dis. 2007; 50: 1-4
25. Fabsitz R, Feinleib M. Geographic patterns in county mortality rates from cardiovascular diseases. Am J Epidemiol. 1980; 111: 315-328
26. Zipes DP. Warning: the short days of winter may be hazardous to your health. Circulation. 1999; 100: 1590-1592
27. Teng M, Wolf M, Ofsthun MN, et al. Activated injectable vitamin D and hemodialysis: a historical cohort study. J Am Soc Nephrol. 2005; 16: 1115-1125
28. Autier P, Gandini S. Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. Arch Intern Med. 2007; 167: 1730-1737
29. Amrein K, Sourij H, Wagner G, et al. Short-term effects of highdose oral vitamin D3 in critically ill vitamin D deficient patients: a randomized, double-blind, placebo-controlled pilot study. Crit Care. 2011; 15: R104
30. Halkin A, Singh M, Nikolsky E, et al. Prediction of mortality after primary percutaneous coronary intervention for acute myocardial infarction: the CADILLAC risk score. J Am Coll Cardiol. 2005; 45: 1397-1405
31. Marenzi G, Moltrasio M, Assanelli E, et al. Impact of cardiac and renal dysfunction on in hospital morbidity and mortality of patients with acute myocardial infarction undergoing primary angioplasty. Am Heart J. 2007; 153: 755-762
32. Saltzman AJ, Stone GW, Claessen BE, et al. Long-term impact of chronic kidney disease in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention. The HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial. J Am Coll Cardiol Intv. 2011; 4: 1011-1019
33. Pittas AG, Chung M, Trikalinos T, et al. Systemic review: vitamin D and cardiometabolic outcomes. Ann Intern Med. 2010; 152: 307-314
34. Herrmann M, Sullivan DR, Veillard AS, et al. FIELD Study Investigators. Serum 25-hydroxyvitamin d: a predictor of macrovascular and microvascular complications in patients with type 2 diabetes. Diabetes Care. 2015; 38: 521-528
35. Monraats PS, Fang Y, Pons D, et al. Vitamin D receptor: a new risk marker for clinical restenosis after percutaneous coronary intervention. Expert Opin Ther Targets. 2010; 14: 243-251
36. Jorde R, Grimnes G. Vitamin D and metabolic health with special reference to the effect of vitamin D on serum lipids. Prog Lipid Res. 2011; 50: 303-312
37. Wu L, Liu L. Systematic Review and Meta-Analysis Evaluating the Impact of Vitamin D on the Risk of Heart Failure: New Evidence from Population-based Studies. JCvD. 2014; 2: 159-173
38. Stach K, Kalsch AI, Nguyen XD, et al. 1alpha,25-dihydroxyvitamin D3 attenuates platelet activation and the expression of VCAM-1 and MT1-MMP in human endothelial cells. Cardiology. 2011; 118: 107-115
39. Perticone F, Ceravolo R, Pujia A, et al. Prognostic significance of endothelial dysfunction in hypertensive patients. Circulation. 2001; 104: 191-196
40. Kinlay S, Ganz P. Relation between endothelial dysfunction and the acute coronary syndrome: implications for therapy. Am J Cardiol. 2000; 86: 10J-13Jdiscussion 13J-14J
41. Santulli G, Campanile A, Spinelli L, et al. G protein-coupled receptor kinase 2 in patients with acute myocardial infarction. Am J Cardiol. 2011; 107: 1125-1130
42. Iaccarino G, Ciccarelli M, Sorriento D, et al. AKT participates in endothelial dysfunction in hypertension. Circulation. 2004; 109: 2587-2593
43. Eren E, Ellidag HY, Yilmaz A, et al. No association between vitamin D levels and inflammation markers in patients with acute coronary syndrome. Adv Med Sci. 2015; 60: 89-93
44. Rosen CJ. Vitamin D insufficiency. N Engl J Med. 2011; 364: 248-254
45. Ohsawa M, Koyama T, Yamamoto K, et al. 1alpha,25-Dihydroxyvitamin D (3) and its potent synthetic analogs downregulate tissue factor and upregulate thrombomodulin expression in monocytic cells, counteracting the effects of tumor necrosis factor and oxidized LDL. Circulation. 2000; 102: 2867-2872
46. Benigni A, Livio M, Dodesini P, et al. Inhibition of human platelet aggregation by parathyroid hormone: is cyclic AMP implicated?. Am J Nephrol. 1985; 5: 243-247
47. WuWong JR, Nakane M, Chen Y, et al. Different Effects of calcidiol and Calcitriol on Regulating Vitamine D Receptor Target Gene Expression in Human Vascular Smooth Muscle Cells. JCvD. 2013; 1: 15-20
48. Jaworski K, Maslanka K, Kosior DA. Transfusion-related acute lung injury: A dangerous and underdiagnosed noncardiogenic pulmonary edema. Cardiol J. 2013; 20: 337-344